 David Brumbaugh
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medical Marijuana | 2 | 2021 | 114 | 1.380 |
Why?
| | Foreign Bodies | 5 | 2020 | 94 | 1.240 |
Why?
| | Esophagus | 4 | 2018 | 239 | 0.990 |
Why?
| | Advisory Committees | 2 | 2020 | 220 | 0.890 |
Why?
| | Clostridium Infections | 2 | 2023 | 55 | 0.860 |
Why?
| | Muscular Dystrophy, Duchenne | 2 | 2018 | 79 | 0.810 |
Why?
| | Fatty Liver | 2 | 2013 | 277 | 0.790 |
Why?
| | Organizational Policy | 1 | 2020 | 77 | 0.770 |
Why?
| | Specialties, Surgical | 1 | 2020 | 70 | 0.750 |
Why?
| | Fecal Microbiota Transplantation | 2 | 2023 | 14 | 0.720 |
Why?
| | Esophagoscopy | 2 | 2018 | 192 | 0.720 |
Why?
| | Nutrition Disorders | 1 | 2018 | 22 | 0.710 |
Why?
| | Electric Power Supplies | 4 | 2020 | 46 | 0.710 |
Why?
| | Dilatation | 1 | 2018 | 58 | 0.690 |
Why?
| | Epidermolysis Bullosa | 1 | 2018 | 39 | 0.690 |
Why?
| | Esophageal Stenosis | 1 | 2018 | 49 | 0.690 |
Why?
| | Fluoroscopy | 1 | 2018 | 139 | 0.670 |
Why?
| | Feces | 2 | 2017 | 366 | 0.660 |
Why?
| | Hospitals, Pediatric | 2 | 2021 | 488 | 0.650 |
Why?
| | Surgeons | 1 | 2020 | 204 | 0.630 |
Why?
| | Diarrhea | 1 | 2017 | 172 | 0.610 |
Why?
| | Pharynx | 1 | 2016 | 52 | 0.600 |
Why?
| | Gastrointestinal Diseases | 1 | 2018 | 204 | 0.600 |
Why?
| | Intestines | 2 | 2016 | 320 | 0.580 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 118 | 0.580 |
Why?
| | Informed Consent | 1 | 2016 | 160 | 0.540 |
Why?
| | Endoscopy, Gastrointestinal | 2 | 2016 | 201 | 0.510 |
Why?
| | Gastroenterology | 1 | 2016 | 149 | 0.500 |
Why?
| | Gastrointestinal Hemorrhage | 2 | 2011 | 109 | 0.480 |
Why?
| | Microbiota | 2 | 2016 | 538 | 0.470 |
Why?
| | Hyperbilirubinemia | 1 | 2012 | 15 | 0.460 |
Why?
| | Muscle Cells | 1 | 2012 | 43 | 0.440 |
Why?
| | Intra-Abdominal Fat | 1 | 2012 | 89 | 0.430 |
Why?
| | Diabetes, Gestational | 2 | 2012 | 285 | 0.430 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2013 | 170 | 0.430 |
Why?
| | Esophageal Diseases | 1 | 2011 | 30 | 0.420 |
Why?
| | Child | 12 | 2023 | 18649 | 0.420 |
Why?
| | Adiposity | 2 | 2012 | 504 | 0.400 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 524 | 0.400 |
Why?
| | Obesity | 2 | 2013 | 2711 | 0.380 |
Why?
| | Infant | 7 | 2020 | 8255 | 0.370 |
Why?
| | Lipid Metabolism | 1 | 2012 | 525 | 0.340 |
Why?
| | Pediatrics | 1 | 2016 | 1021 | 0.330 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2013 | 499 | 0.320 |
Why?
| | Energy Metabolism | 1 | 2013 | 921 | 0.310 |
Why?
| | Hemorrhage | 1 | 2011 | 605 | 0.310 |
Why?
| | Neoplasms | 1 | 2021 | 2139 | 0.310 |
Why?
| | Child, Preschool | 9 | 2020 | 9714 | 0.300 |
Why?
| | Humans | 25 | 2023 | 117635 | 0.270 |
Why?
| | Liver | 1 | 2013 | 1856 | 0.270 |
Why?
| | Vascular Fistula | 2 | 2016 | 15 | 0.250 |
Why?
| | Esophageal Fistula | 2 | 2016 | 20 | 0.250 |
Why?
| | Insulin Resistance | 1 | 2012 | 1163 | 0.250 |
Why?
| | Mineral Oil | 1 | 2002 | 3 | 0.230 |
Why?
| | Pneumonia, Aspiration | 1 | 2002 | 15 | 0.230 |
Why?
| | Retrospective Studies | 5 | 2023 | 12331 | 0.230 |
Why?
| | Brain Abscess | 1 | 2021 | 11 | 0.220 |
Why?
| | Adolescent | 6 | 2023 | 18903 | 0.220 |
Why?
| | Parents | 2 | 2021 | 1163 | 0.210 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3214 | 0.200 |
Why?
| | Federal Government | 1 | 2020 | 30 | 0.200 |
Why?
| | Diagnostic Errors | 1 | 2021 | 161 | 0.200 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 1717 | 0.200 |
Why?
| | State Government | 1 | 2020 | 49 | 0.200 |
Why?
| | Female | 12 | 2020 | 63249 | 0.200 |
Why?
| | Recurrence | 3 | 2023 | 1010 | 0.190 |
Why?
| | Morbidity | 1 | 2020 | 262 | 0.190 |
Why?
| | Legislation, Drug | 1 | 2020 | 68 | 0.190 |
Why?
| | Pregnancy | 4 | 2016 | 5554 | 0.180 |
Why?
| | Single-Balloon Enteroscopy | 1 | 2018 | 4 | 0.180 |
Why?
| | Magnets | 1 | 2018 | 15 | 0.180 |
Why?
| | Medical Oncology | 1 | 2021 | 221 | 0.180 |
Why?
| | Infant, Newborn | 3 | 2016 | 5230 | 0.180 |
Why?
| | Treatment Outcome | 5 | 2023 | 9353 | 0.180 |
Why?
| | Male | 11 | 2021 | 60403 | 0.180 |
Why?
| | Patient Safety | 1 | 2021 | 310 | 0.170 |
Why?
| | Nutritional Requirements | 1 | 2018 | 91 | 0.170 |
Why?
| | Endocrine System | 1 | 2018 | 23 | 0.170 |
Why?
| | Neuromuscular Junction | 1 | 2018 | 52 | 0.170 |
Why?
| | Body Composition | 2 | 2012 | 765 | 0.160 |
Why?
| | Stomach | 1 | 2017 | 94 | 0.160 |
Why?
| | Intubation, Gastrointestinal | 1 | 2017 | 59 | 0.160 |
Why?
| | Intestine, Small | 1 | 2018 | 147 | 0.160 |
Why?
| | Down Syndrome | 1 | 2002 | 329 | 0.160 |
Why?
| | Gastrostomy | 1 | 2017 | 89 | 0.160 |
Why?
| | Nutritional Status | 1 | 2018 | 291 | 0.150 |
Why?
| | Quality Improvement | 2 | 2020 | 940 | 0.150 |
Why?
| | Gastrointestinal Tract | 1 | 2018 | 161 | 0.140 |
Why?
| | Colonoscopy | 1 | 2017 | 193 | 0.140 |
Why?
| | Rectum | 1 | 2016 | 153 | 0.140 |
Why?
| | Referral and Consultation | 1 | 2020 | 671 | 0.140 |
Why?
| | Disclosure | 1 | 2016 | 107 | 0.140 |
Why?
| | Vagina | 1 | 2016 | 154 | 0.130 |
Why?
| | Cohort Studies | 2 | 2017 | 5113 | 0.130 |
Why?
| | Risk Factors | 3 | 2013 | 9126 | 0.130 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1029 | 0.130 |
Why?
| | Sequence Analysis, DNA | 1 | 2016 | 706 | 0.120 |
Why?
| | Young Adult | 2 | 2020 | 11079 | 0.120 |
Why?
| | Disease Management | 1 | 2018 | 603 | 0.120 |
Why?
| | Colorado | 2 | 2020 | 4401 | 0.120 |
Why?
| | Cholestasis, Extrahepatic | 1 | 2012 | 7 | 0.120 |
Why?
| | Hepatolenticular Degeneration | 1 | 2012 | 18 | 0.120 |
Why?
| | Choledochal Cyst | 1 | 2012 | 21 | 0.120 |
Why?
| | Gallstones | 1 | 2012 | 29 | 0.110 |
Why?
| | Biliary Tract Diseases | 1 | 2012 | 34 | 0.110 |
Why?
| | Alagille Syndrome | 1 | 2012 | 30 | 0.110 |
Why?
| | Hepatitis A | 1 | 2012 | 28 | 0.110 |
Why?
| | Bilirubin | 1 | 2012 | 84 | 0.110 |
Why?
| | Aspartate Aminotransferases | 1 | 2012 | 101 | 0.110 |
Why?
| | Intracellular Space | 1 | 2012 | 80 | 0.110 |
Why?
| | Alanine Transaminase | 1 | 2012 | 148 | 0.110 |
Why?
| | Skin | 1 | 2016 | 699 | 0.110 |
Why?
| | Puberty | 1 | 2012 | 136 | 0.100 |
Why?
| | Neonatal Screening | 1 | 2012 | 185 | 0.100 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2013 | 288 | 0.100 |
Why?
| | Biliary Atresia | 1 | 2012 | 210 | 0.090 |
Why?
| | Jejunal Diseases | 1 | 2009 | 7 | 0.090 |
Why?
| | Liver Diseases | 1 | 2012 | 278 | 0.090 |
Why?
| | Capsule Endoscopy | 1 | 2009 | 17 | 0.090 |
Why?
| | Epigenesis, Genetic | 1 | 2013 | 503 | 0.090 |
Why?
| | Trachea | 1 | 2011 | 221 | 0.090 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 409 | 0.090 |
Why?
| | Decision Making | 1 | 2016 | 806 | 0.090 |
Why?
| | Metformin | 1 | 2012 | 291 | 0.090 |
Why?
| | Aorta | 1 | 2011 | 425 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1405 | 0.080 |
Why?
| | Phenotype | 1 | 2013 | 2875 | 0.070 |
Why?
| | Adult | 3 | 2023 | 32120 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2012 | 2948 | 0.070 |
Why?
| | Prospective Studies | 1 | 2016 | 6422 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2206 | 0.070 |
Why?
| | Age Factors | 1 | 2012 | 3223 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2011 | 1524 | 0.060 |
Why?
| | Bronchoalveolar Lavage | 1 | 2002 | 93 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 2 | 2021 | 2462 | 0.050 |
Why?
| | Headache Disorders, Secondary | 1 | 2021 | 16 | 0.050 |
Why?
| | Constipation | 1 | 2002 | 65 | 0.050 |
Why?
| | Neurologic Examination | 1 | 2021 | 125 | 0.050 |
Why?
| | Biomarkers | 1 | 2012 | 3574 | 0.050 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2001 | 50 | 0.050 |
Why?
| | Reoviridae | 1 | 2001 | 39 | 0.050 |
Why?
| | Endopeptidases | 1 | 2001 | 75 | 0.050 |
Why?
| | Family Health | 1 | 2021 | 190 | 0.050 |
Why?
| | X Chromosome | 1 | 2000 | 53 | 0.050 |
Why?
| | Fatal Outcome | 1 | 2021 | 305 | 0.050 |
Why?
| | Prednisone | 1 | 2021 | 250 | 0.050 |
Why?
| | Agammaglobulinemia | 1 | 2000 | 33 | 0.050 |
Why?
| | Sucralfate | 1 | 2020 | 2 | 0.050 |
Why?
| | Capsid | 1 | 2001 | 104 | 0.050 |
Why?
| | Leucine | 1 | 2001 | 123 | 0.050 |
Why?
| | Capsid Proteins | 1 | 2001 | 111 | 0.050 |
Why?
| | Arthritis, Infectious | 1 | 2000 | 51 | 0.050 |
Why?
| | Critical Pathways | 1 | 2020 | 69 | 0.050 |
Why?
| | Deglutition | 1 | 2020 | 64 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2000 | 97 | 0.050 |
Why?
| | Information Dissemination | 1 | 2020 | 184 | 0.040 |
Why?
| | Needs Assessment | 1 | 2020 | 343 | 0.040 |
Why?
| | Interprofessional Relations | 1 | 2020 | 276 | 0.040 |
Why?
| | Nutrition Therapy | 1 | 2018 | 33 | 0.040 |
Why?
| | Migraine Disorders | 1 | 2021 | 211 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2001 | 363 | 0.040 |
Why?
| | Eating | 1 | 2020 | 382 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2021 | 556 | 0.040 |
Why?
| | Program Evaluation | 1 | 2020 | 870 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2016 | 158 | 0.030 |
Why?
| | Animals | 2 | 2013 | 34350 | 0.030 |
Why?
| | Pandemics | 1 | 2020 | 1155 | 0.030 |
Why?
| | Patient Care Team | 1 | 2016 | 524 | 0.030 |
Why?
| | Time Factors | 1 | 2002 | 6906 | 0.020 |
Why?
| | Prednisolone | 1 | 2009 | 76 | 0.020 |
Why?
| | Algorithms | 1 | 2016 | 1550 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 524 | 0.020 |
Why?
| | Cathepsin L | 1 | 2001 | 8 | 0.010 |
Why?
| | Cathepsin D | 1 | 2001 | 14 | 0.010 |
Why?
| | Cathepsins | 1 | 2001 | 19 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 2001 | 59 | 0.010 |
Why?
| | Virus Assembly | 1 | 2001 | 77 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2000 | 303 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2001 | 530 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2009 | 4911 | 0.010 |
Why?
| | Streptococcus pneumoniae | 1 | 2000 | 130 | 0.010 |
Why?
| | Risk Assessment | 1 | 2009 | 3208 | 0.010 |
Why?
| | Knee Joint | 1 | 2000 | 329 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2001 | 524 | 0.010 |
Why?
| | Mutation | 1 | 2001 | 3409 | 0.010 |
Why?
| | Mice | 1 | 2001 | 15537 | 0.000 |
Why?
|
|
Brumbaugh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|